Sands Capital Management, Llc
Source: SEC Form 13F · as of Mar 2026Sands Capital Management, Llc holds 4 biotech & pharma companies tracked by BioSniper, totaling $520.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
4
Total value held
$520.3M
BioSniper AIPage evidence connected
Prepared research question
What matters most for ARGENX SE (ARGX)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ARGXARGENX SE | 340,285 | $248.5M |
| MCKMcKesson Corporation | 201,283 | $174.2M |
| RAREUltragenyx Pharmaceutical Inc. | 3,214,533 | $67.3M |
| LLYELI LILLY & Co | 32,887 | $30.2M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.